---
title: "Beta Bionics Announces Second Quarter 2026 Financial Results and Updates Full Year 2026 Guidance"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294255779.md"
description: "On July 29, 2026, in Irvine, California, Beta Bionics, Inc. (Nasdaq: BBNX), a company focused on innovative diabetes management solutions, shared its financial performance for the quarter concluding on June 30, 2026. The company also revised its annual guidance for the year ending on December 31, 2026."
datetime: "2026-07-29T20:04:42.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294255779.md)
  - [en](https://longbridge.com/en/news/294255779.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294255779.md)
generator: "portal-rs"
---

# Beta Bionics Announces Second Quarter 2026 Financial Results and Updates Full Year 2026 Guidance

On July 29, 2026, in Irvine, California, Beta Bionics, Inc. (Nasdaq: BBNX), a company focused on innovative diabetes management solutions, shared its financial performance for the quarter concluding on June 30, 2026. The company also revised its annual guidance for the year ending on December 31, 2026.

### Related Stocks

- [BBNX.US](https://longbridge.com/en/quote/BBNX.US.md)

## Related News & Research

- [Beta Bionics CEO Sean Saint disposes of 5,641 common shares for $113,261.01](https://longbridge.com/en/news/298077212.md)
- [Have Beta Bionics Insiders Been Selling Stock?](https://longbridge.com/en/news/298111067.md)
- [Beta Bionics (NASDAQ:BBNX) Insider Sells 4,221 Shares of Stock](https://longbridge.com/en/news/298030991.md)
- [Marisa updates financial events calendar for 2026](https://longbridge.com/en/news/297913424.md)
- [Pininfarina announces availability of H1 2026 interim financial report](https://longbridge.com/en/news/298044460.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**